Alpine Global Management, LLC Spectrum Pharmaceuticals Inc Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.63 - $1.59 $61,519 - $155,263	-97,650 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $98,623 - $187,927	77,656 Added 388.4%	97,650 $124,000
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.82 $42,987 - $76,377	19,994 New	19,994 $47,000
Q1 2020 Apr 09, 2020	SELL	$1.83 - $3.45 $308,706 - $581,987	-168,692 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$3.5 - $10.35 $590,422 - $1.75 Million	168,692 New	168,692 $614,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.